You Q, Tong X, Guan Y, Zhang D, Huang M, Zhang Y, Zheng J
Stem Cell Investigation Centre, Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, China.
J Int Med Res. 2009 Jan-Feb;37(1):105-12. doi: 10.1177/147323000903700112.
Third trimester amniotic fluid (AF)-derived human mesenchymal stem cells (MSCs) can be greatly expanded in vitro and induced to differentiate into multiple mesenchymal cell types. This study aimed to investigate the biological characteristics of MSCs from third trimester AF as a new source of therapeutic stem cells. Forty third trimester AF samples were obtained from healthy women who underwent elective caesarean section for breech presentation. A simple culture protocol for MSCs was used. A cell growth curve was drawn, and cell surface antigens and cytokines were analysed by immunofluorescent staining, reverse transcription-polymerase chain reaction and flow cytometry. MSCs from third-trimester AF were successfully isolated, cultured and enriched. MSCs expanded extensively without feeders, they were not tumourigenic and were induced to differentiate into osteocytes. Surface antigens were analysed and found to express the pluripotency marker Oct-4. Considering the great feasibility of biomedical engineering using MSCs, third trimester AF may provide a rich source for investigation of human MSCs.
孕晚期羊水(AF)来源的人间充质干细胞(MSCs)可在体外大量扩增,并诱导分化为多种间充质细胞类型。本研究旨在探讨孕晚期AF来源的MSCs作为治疗性干细胞新来源的生物学特性。从因臀位行择期剖宫产的健康女性中获取40份孕晚期AF样本。采用一种简单的MSCs培养方案。绘制细胞生长曲线,并通过免疫荧光染色、逆转录-聚合酶链反应和流式细胞术分析细胞表面抗原和细胞因子。成功分离、培养和富集了孕晚期AF来源的MSCs。MSCs在无饲养层的情况下广泛扩增,无致瘤性,并被诱导分化为骨细胞。分析表面抗原,发现其表达多能性标志物Oct-4。考虑到使用MSCs进行生物医学工程的巨大可行性,孕晚期AF可能为研究人MSCs提供丰富来源。